COO
NASDAQ · Health Care
Cooper Cos Inc/The
$71.45
+0.96 (+1.36%)
Financial Highlights (FY 2026)
Revenue
3.94B
Net Income
361.31M
Gross Margin
65.5%
Profit Margin
9.2%
Rev Growth
+7.4%
D/E Ratio
0.30
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 65.5% | 65.5% | 31.1% | 31.1% |
| Operating Margin | 16.7% | 15.0% | 19.1% | 18.3% |
| Profit Margin | 9.2% | 8.7% | 15.2% | 14.5% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 3.94B | 3.67B | 3.04B | 3.62B |
| Gross Profit | 2.58B | 2.41B | 946.19M | 1.12B |
| Operating Income | 658.26M | 551.87M | 582.14M | 660.89M |
| Net Income | 361.31M | 302.92M | 462.64M | 523.71M |
| Gross Margin | 65.5% | 65.5% | 31.1% | 31.1% |
| Operating Margin | 16.7% | 15.0% | 19.1% | 18.3% |
| Profit Margin | 9.2% | 8.7% | 15.2% | 14.5% |
| Rev Growth | +7.4% | +7.4% | +17.9% | +23.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.90B | 1.90B | 2.83B | 2.88B |
| Total Equity | 6.24B | 6.24B | 11.16B | 10.53B |
| D/E Ratio | 0.30 | 0.30 | 0.25 | 0.27 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 842.03M | 745.16M | 674.55M | 906.37M |
| Free Cash Flow | — | — | 297.18M | 404.54M |